Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.
Publication
, Journal Article
Russo, S; Walker, JL; Carlson, JW; Carter, J; Ward, LC; Covens, A; Tanner, EJ; Armer, JM; Ridner, S; Hayes, S; Taghian, AG; Brunelle, C ...
Published in: Gynecol Oncol
February 2021
Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
February 2021
Volume
160
Issue
2
Start / End Page
625 / 632
Location
United States
Related Subject Headings
- Treatment Outcome
- Sentinel Lymph Node Biopsy
- Risk Factors
- Radiotherapy, Adjuvant
- Patient Reported Outcome Measures
- Organ Size
- Oncology & Carcinogenesis
- Lymphedema
- Lymph Node Excision
- Lower Extremity
Citation
APA
Chicago
ICMJE
MLA
NLM
Russo, S., Walker, J. L., Carlson, J. W., Carter, J., Ward, L. C., Covens, A., … McCaskill-Stevens, W. (2021). Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol, 160(2), 625–632. https://doi.org/10.1016/j.ygyno.2020.10.026
Russo, Sandra, Joan L. Walker, Jay W. Carlson, Jeanne Carter, Leigh C. Ward, Allan Covens, Edward J. Tanner, et al. “Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.” Gynecol Oncol 160, no. 2 (February 2021): 625–32. https://doi.org/10.1016/j.ygyno.2020.10.026.
Russo S, Walker JL, Carlson JW, Carter J, Ward LC, Covens A, et al. Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol. 2021 Feb;160(2):625–32.
Russo, Sandra, et al. “Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.” Gynecol Oncol, vol. 160, no. 2, Feb. 2021, pp. 625–32. Pubmed, doi:10.1016/j.ygyno.2020.10.026.
Russo S, Walker JL, Carlson JW, Carter J, Ward LC, Covens A, Tanner EJ, Armer JM, Ridner S, Hayes S, Taghian AG, Brunelle C, Lopez-Acevedo M, Davidson BA, Schaverien MV, Ghamande SA, Bernas M, Cheville AL, Yost KJ, Schmitz K, Coyle B, Zucker J, Enserro D, Pugh S, Paskett ED, Ford L, McCaskill-Stevens W. Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecol Oncol. 2021 Feb;160(2):625–632.
Published In
Gynecol Oncol
DOI
EISSN
1095-6859
Publication Date
February 2021
Volume
160
Issue
2
Start / End Page
625 / 632
Location
United States
Related Subject Headings
- Treatment Outcome
- Sentinel Lymph Node Biopsy
- Risk Factors
- Radiotherapy, Adjuvant
- Patient Reported Outcome Measures
- Organ Size
- Oncology & Carcinogenesis
- Lymphedema
- Lymph Node Excision
- Lower Extremity